Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…
DelveInsight's "Interstitial Cystitis - Epidemiology Insights -2023" Reports provides an overview of the disease. The Report includes global forecast of epidemiology of Interstitial Cystitis till 2023. Interstitial cystitis (IC) also known as painful bladder syndrome is a chronic disease that results in recurring discomfort or pain in the bladder and the surrounding pelvic region. This is considered as multiple bladder condition as it can lead to many other problems. Current studies estimate that 2.7% to 6.5% of women in the United States have symptoms consistent with a diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS). PBS/IC is more common in women, with a female/male ratio that ranges from 5:1 to 10:1 and the Median age at diagnosis is 42 to 46 yr old whereas men are diagnosed at a younger age. According to DelveInsight, the number of Incident Probable IC cases in 7 major markets is expected to reach 1,97,086 cases in 2023. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
The report will help in developing business strategies by understanding the trends shaping and driving the global Interstitial Cystitis scenario.
Review of the key market drivers and barriers.
To understand the regulatory scenario in major markets.
The Report covers the detailed global historical and forecasted Interstitial Cystitis Epidemiology covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.